What a p(doom) figure needs to specify before boards, insurers, and regulators can use it in a decision.

How leadership teams can hold a defensible position when executives and investors disagree on measuring AI spend by tokens or by outcomes.

How AI transformation shifts who captures value when a family business is sold, and what a family can do in the years before a sale.

Frontier AI models change after they are licensed, and enterprise contracts and governance tend to assume they do not.

What a board-level chokepoint inventory covers: the critical dependencies, an owner for each, and a contingency.